4//SEC Filing
Giuffre Randall Michael 4
Accession 0001235802-23-000004
CIK 0001401040other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:43 PM ET
Size
7.0 KB
Accession
0001235802-23-000004
Insider Transaction Report
Form 4
Giuffre Randall Michael
Director
Transactions
- Award
Voting Common Shares, no par value per share
2023-01-03$1.53/sh+35,130$53,749→ 295,355 total
Holdings
- 21,070(indirect: By Spouse)
Voting Common Shares, no par value per share
- 25,573(indirect: See footnote)
Voting Common Shares, no par value per share
Footnotes (3)
- [F1]These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750.
- [F2]Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 64,959 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually.
- [F3]These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001759822
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:43 PM ET
- Size
- 7.0 KB